Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea

Young Tak Kim, Beatriz Serrano, Jae Kwan Lee, Hyunju Lee, Shin Wha Lee, Crystal Freeman, Jin Kyoung Oh, Laia Alemany, Francesc Xavier Bosch, Laia Bruni

Research output: Contribution to journalArticle

Abstract

Background: We aimed to review the burden and the potential impact of human papillomavirus (HPV) vaccines on HPV-related diseases in the Republic of Korea and to discuss cervical cancer prevention practices in this country. Methods: Cancer burden statistics were retrieved from GLOBOCAN-2018 and Statistics Korea. HPV disease burden was assessed via systematic review. Vaccine types relative contribution (RC) was estimated using data from an international project using formalin-fixed paraffin-embedded specimens. Results: Despite a downtrend in cervical cancer in recent years, Korean rates remain high. In contrast, oropharyngeal cancer incidence has gradually increased and other anogenital cancers remain rare. In Korea, HPV prevalence in general population is around 20%. In cervical cancer, RC of HPVs 16/18 (74.0%) increased to 92.0% when including HPVs 31/33/45/52/58. Limited information was available for other HPV-related cancer sites. Regarding prevention, since the inclusion of the HPV vaccine into the National Immunization Program, almost half (49%) of the target cohort in 2016 had received the first dose of vaccine. Further, percentage of women screened with pap has increased from 41.1%-2009 to 53.0%-2016. Conclusions: HPV-related disease burden in Korea is significant. Results suggest that the combination of effective and high coverage HPV vaccination and screening programmes could substantially impact on HPV-related disease in Korea.

Original languageEnglish
Pages (from-to)26-42
Number of pages17
JournalPapillomavirus Research
Volume7
DOIs
Publication statusPublished - 2019 Jun 1

Fingerprint

Papillomavirus Vaccines
Republic of Korea
Korea
Uterine Cervical Neoplasms
Human papillomavirus 31
Vaccines
Oropharyngeal Neoplasms
Human papillomavirus 18
Neoplasms
Immunization Programs
Human papillomavirus 16
Paraffin
Formaldehyde
Vaccination
Incidence
Population

Keywords

  • Burden
  • Cancer
  • Cervical cancer screening
  • Human papillomavirus
  • Papillomavirus vaccine
  • Republic of Korea

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea. / Kim, Young Tak; Serrano, Beatriz; Lee, Jae Kwan; Lee, Hyunju; Lee, Shin Wha; Freeman, Crystal; Oh, Jin Kyoung; Alemany, Laia; Bosch, Francesc Xavier; Bruni, Laia.

In: Papillomavirus Research, Vol. 7, 01.06.2019, p. 26-42.

Research output: Contribution to journalArticle

Kim, Young Tak ; Serrano, Beatriz ; Lee, Jae Kwan ; Lee, Hyunju ; Lee, Shin Wha ; Freeman, Crystal ; Oh, Jin Kyoung ; Alemany, Laia ; Bosch, Francesc Xavier ; Bruni, Laia. / Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea. In: Papillomavirus Research. 2019 ; Vol. 7. pp. 26-42.
@article{f7d9c0da8a2241c19fd510e1bfa9c68f,
title = "Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea",
abstract = "Background: We aimed to review the burden and the potential impact of human papillomavirus (HPV) vaccines on HPV-related diseases in the Republic of Korea and to discuss cervical cancer prevention practices in this country. Methods: Cancer burden statistics were retrieved from GLOBOCAN-2018 and Statistics Korea. HPV disease burden was assessed via systematic review. Vaccine types relative contribution (RC) was estimated using data from an international project using formalin-fixed paraffin-embedded specimens. Results: Despite a downtrend in cervical cancer in recent years, Korean rates remain high. In contrast, oropharyngeal cancer incidence has gradually increased and other anogenital cancers remain rare. In Korea, HPV prevalence in general population is around 20{\%}. In cervical cancer, RC of HPVs 16/18 (74.0{\%}) increased to 92.0{\%} when including HPVs 31/33/45/52/58. Limited information was available for other HPV-related cancer sites. Regarding prevention, since the inclusion of the HPV vaccine into the National Immunization Program, almost half (49{\%}) of the target cohort in 2016 had received the first dose of vaccine. Further, percentage of women screened with pap has increased from 41.1{\%}-2009 to 53.0{\%}-2016. Conclusions: HPV-related disease burden in Korea is significant. Results suggest that the combination of effective and high coverage HPV vaccination and screening programmes could substantially impact on HPV-related disease in Korea.",
keywords = "Burden, Cancer, Cervical cancer screening, Human papillomavirus, Papillomavirus vaccine, Republic of Korea",
author = "Kim, {Young Tak} and Beatriz Serrano and Lee, {Jae Kwan} and Hyunju Lee and Lee, {Shin Wha} and Crystal Freeman and Oh, {Jin Kyoung} and Laia Alemany and Bosch, {Francesc Xavier} and Laia Bruni",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.pvr.2018.12.002",
language = "English",
volume = "7",
pages = "26--42",
journal = "Papillomavirus Research",
issn = "2405-8521",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea

AU - Kim, Young Tak

AU - Serrano, Beatriz

AU - Lee, Jae Kwan

AU - Lee, Hyunju

AU - Lee, Shin Wha

AU - Freeman, Crystal

AU - Oh, Jin Kyoung

AU - Alemany, Laia

AU - Bosch, Francesc Xavier

AU - Bruni, Laia

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Background: We aimed to review the burden and the potential impact of human papillomavirus (HPV) vaccines on HPV-related diseases in the Republic of Korea and to discuss cervical cancer prevention practices in this country. Methods: Cancer burden statistics were retrieved from GLOBOCAN-2018 and Statistics Korea. HPV disease burden was assessed via systematic review. Vaccine types relative contribution (RC) was estimated using data from an international project using formalin-fixed paraffin-embedded specimens. Results: Despite a downtrend in cervical cancer in recent years, Korean rates remain high. In contrast, oropharyngeal cancer incidence has gradually increased and other anogenital cancers remain rare. In Korea, HPV prevalence in general population is around 20%. In cervical cancer, RC of HPVs 16/18 (74.0%) increased to 92.0% when including HPVs 31/33/45/52/58. Limited information was available for other HPV-related cancer sites. Regarding prevention, since the inclusion of the HPV vaccine into the National Immunization Program, almost half (49%) of the target cohort in 2016 had received the first dose of vaccine. Further, percentage of women screened with pap has increased from 41.1%-2009 to 53.0%-2016. Conclusions: HPV-related disease burden in Korea is significant. Results suggest that the combination of effective and high coverage HPV vaccination and screening programmes could substantially impact on HPV-related disease in Korea.

AB - Background: We aimed to review the burden and the potential impact of human papillomavirus (HPV) vaccines on HPV-related diseases in the Republic of Korea and to discuss cervical cancer prevention practices in this country. Methods: Cancer burden statistics were retrieved from GLOBOCAN-2018 and Statistics Korea. HPV disease burden was assessed via systematic review. Vaccine types relative contribution (RC) was estimated using data from an international project using formalin-fixed paraffin-embedded specimens. Results: Despite a downtrend in cervical cancer in recent years, Korean rates remain high. In contrast, oropharyngeal cancer incidence has gradually increased and other anogenital cancers remain rare. In Korea, HPV prevalence in general population is around 20%. In cervical cancer, RC of HPVs 16/18 (74.0%) increased to 92.0% when including HPVs 31/33/45/52/58. Limited information was available for other HPV-related cancer sites. Regarding prevention, since the inclusion of the HPV vaccine into the National Immunization Program, almost half (49%) of the target cohort in 2016 had received the first dose of vaccine. Further, percentage of women screened with pap has increased from 41.1%-2009 to 53.0%-2016. Conclusions: HPV-related disease burden in Korea is significant. Results suggest that the combination of effective and high coverage HPV vaccination and screening programmes could substantially impact on HPV-related disease in Korea.

KW - Burden

KW - Cancer

KW - Cervical cancer screening

KW - Human papillomavirus

KW - Papillomavirus vaccine

KW - Republic of Korea

UR - http://www.scopus.com/inward/record.url?scp=85059668434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059668434&partnerID=8YFLogxK

U2 - 10.1016/j.pvr.2018.12.002

DO - 10.1016/j.pvr.2018.12.002

M3 - Article

C2 - 30599280

AN - SCOPUS:85059668434

VL - 7

SP - 26

EP - 42

JO - Papillomavirus Research

JF - Papillomavirus Research

SN - 2405-8521

ER -